EPISODE · Apr 13, 2018 · 25 MIN
S1 Ep3: The Gene-Editing Company That Didn't Need CRISPR
from Data Book · host Inside Digital Health™
CRISPR, TALEN, and gene editing sound like the stuff of the future, but they are already changing medicine. What about zinc finger nucleases? That's what Sangamo Therapeutics uses to perform gene editing, and the tech recently earned the company a $3 billion deal. Today on Data Book, the origins of CRISPR and the Sangamo story.
Embed this episode
Ready to play
S1 Ep3: The Gene-Editing Company That Didn't Need CRISPR
0:00
25:49
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Data Book?
This episode is 25 minutes long.
When was this Data Book episode published?
This episode was published on April 13, 2018.
Can I download this Data Book episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!